Clinical Trial Update: A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of SAR441566 in adults with rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SAR441566 (SAR441566)

Snippet

Sponsor: Sanofi | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED